Cargando…

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings

BACKGROUND: While inferior to oxytocin injection in both efficacy and safety, orally administered misoprostol has been included in the World Health Organization Model List of Essential Medicines for use in the prevention of postpartum haemorrhage (PPH) in low-resource settings. This study evaluates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Danielle L., Zhao, Fei-Li, Robertson, Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655498/ https://www.ncbi.nlm.nih.gov/pubmed/26596797 http://dx.doi.org/10.1186/s12884-015-0749-z

Ejemplares similares

Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?
por: Chatterjee, Susmita, et al.
Publicado: (2016)

Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage
por: Sahhaf, Farnaz, et al.
Publicado: (2014)

Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
por: Nasreen, Hashima-E-, et al.
Publicado: (2011)

Feasibility, Acceptability, and Programme Effectiveness of Misoprostol for Prevention of Postpartum Haemorrhage in Rural Bangladesh: A Quasiexperimental Study
por: Quaiyum, Abdul, et al.
Publicado: (2014)

Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]
por: Hofmeyr, G Justus, et al.
Publicado: (2004)

Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster‐randomised non‐inferiority community trial
por: Raghavan, S, et al.
Publicado: (2016)

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)

How to use heat-stable carbetocin and tranexamic acid for the prevention and treatment of postpartum haemorrhage in low-resource settings
por: Tran, Nguyen Toan, et al.
Publicado: (2022)

Implementing Heat-Stable Carbetocin for Postpartum Haemorrhage Prevention in Low-Resource Settings: A Rapid Scoping Review
por: Tran, Nguyen Toan, et al.
Publicado: (2022)

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2016)

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial
por: Mobeen, N, et al.
Publicado: (2011)

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
por: Rajaei, Minoo, et al.
Publicado: (2014)

Training Traditional Birth Attendants on the Use of Misoprostol and a Blood Measurement Tool to Prevent Postpartum Haemorrhage: Lessons Learnt from Bangladesh
por: Bell, Suzanne, et al.
Publicado: (2014)

Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trial
por: Ononge, Sam, et al.
Publicado: (2015)

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
por: Prata, Ndola, et al.
Publicado: (2014)

Prevention of postpartum hemorrhage in low-resource settings: current perspectives
por: Prata, Ndola, et al.
Publicado: (2013)

Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis
por: Pickering, Karen, et al.
Publicado: (2018)

Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali
por: Dumont, Alexandre, et al.
Publicado: (2017)

Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Influence of nursing interventions in improving midwives’ knowledge of misoprostol use in the management of postpartum haemorrhage at selected hospitals in Ondo State, Nigeria
por: Iwaola, Olufunke Mercy, et al.
Publicado: (2021)

Clinical performance and patient outcome after simulation-based training in prevention and management of postpartum haemorrhage: an educational intervention study in a low-resource setting
por: Nelissen, Ellen, et al.
Publicado: (2017)

Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings
por: Carvalho, Natalie, et al.
Publicado: (2020)

High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010)

Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania)
por: van Beekhuizen, Heleen J, et al.
Publicado: (2009)

Implementing at-scale, community-based distribution of misoprostol tablets to mothers in the third stage of labor for the prevention of postpartum haemorrhage in Sokoto State, Nigeria: Early results and lessons learned
por: Orobaton, Nosakhare, et al.
Publicado: (2017)

The Prevention and Treatment of Postpartum Haemorrhage in Domiciliary Practice
por: McIlroy, Louise
Publicado: (1952)

Misoprostol as an adjunct to oxytocin can reduce postpartum-haemorrhage: a propensity score–matched retrospective chart review in Bamenda-Cameroon, 2015–2016
por: Morfaw, Frederick, et al.
Publicado: (2019)

Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial
por: Dawoud, Mariam, et al.
Publicado: (2023)

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach
por: Koch, Daeska Marcella, et al.
Publicado: (2019)

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date
por: Smith, Jeffrey Michael, et al.
Publicado: (2013)

Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia
por: Smith, Jeffrey Michael, et al.
Publicado: (2014)

Misoprostol for the prevention of post-partum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development
por: Hobday, Karen, et al.
Publicado: (2020)

Current research on carbetocin and implications for prevention of postpartum haemorrhage
por: Theunissen, Fiona J., et al.
Publicado: (2018)

Prevention of postpartum haemorrhage: a distributional approach for analysis
por: Piaggio, Gilda, et al.
Publicado: (2018)

Management of postpartum haemorrhage
por: Bonnet, Marie Pierre, et al.
Publicado: (2016)

Management of Postpartum Haemorrhage
por: Günaydın, Berrin
Publicado: (2022)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
por: Cook, John R., et al.
Publicado: (2023)

Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Xu, Renmei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8i6jg5k37gln7temoa1s3dli1i